How many insider declarations has Satya Vani Nannapaneni filed?

Satya Vani Nannapaneni has filed 4 public insider declarations with SEBI (PIT + SAST).

What is Satya Vani Nannapaneni's role?

Satya Vani Nannapaneni's reported role is not specified by the regulator across the filings.

Which companies does Satya Vani Nannapaneni report trades for?

Satya Vani Nannapaneni reports trades for Natco Pharma Limited.

← Executives ★ Sign in to follow

SV

Satya Vani Nannapaneni

·SEBI (PIT + SAST)

Natco Pharma Limited

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Explore the full record of transactions filed by Satya Vani Nannapaneni. Officer active across 1 company, notably Natco Pharma Limited. In total, 4 filings have been logged. Activity tracked since 28 February 2025. The latest transaction was disclosed on 9 March 2026 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.

Companies and markets linked to Satya Vani Nannapaneni

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Natco Pharma Limited (IN)IN insider transactions · SEBI (PIT + SAST)

申报4 总计

●

SATYA VANI NANNAPANENI

高管2026年3月9日Natco Pharma Limited

₹4506万9SEBI ↗

45,000 股@ ₹1,001.3310.0003% mcap56.1% 占其流量Equity SharesSEBI:e6cac393a77a52cae1534ede84b97186a637e9b0

●

SATYA VANI NANNAPANENI

高管2025年9月16日Natco Pharma Limited

₹1972万5SEBI ↗

23,000 股@ ₹857.391425.2% 占其流量Equity SharesSEBI:16948d1eb5e3ec3fdb2ea5f44509de7f3065cee1

●

SATYA VANI NANNAPANENI

高管2025年9月8日Natco Pharma Limited

₹1452万4SEBI ↗

17,149 股@ ₹846.677418.7% 占其流量Equity SharesSEBI:9ffdd87051e298ebbb63db64f86914adba0a9643

●

SATYA VANI NANNAPANENI

高管2025年2月28日Natco Pharma Limited

2SEBI ↗

420,000 股Equity SharesSEBI:a037f2c7f2c299fd3bf94f3db34b48bc76e937e5

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SV

Satya Vani Nannapaneni

·SEBI (PIT + SAST)

Natco Pharma Limited

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Explore the full record of transactions filed by Satya Vani Nannapaneni. Officer active across 1 company, notably Natco Pharma Limited. In total, 4 filings have been logged. Activity tracked since 28 February 2025. The latest transaction was disclosed on 9 March 2026 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.